Nathalie Lenne

Nathalie Lenne is Vice-President of Strategic Portfolio Management at Kainova Therapeutics. She joined the organization in 2017 to oversee portfolio management, including non-clinical activities, as well as the search, evaluation and negotiation of external opportunities. Nathalie has more than 20 years of experience in project management and strategic cross-functional coordination, working with experts across research, CMC, clinical development, regulatory affairs. In her role, she ensures coherent program progression across therapeutic areas, particularly in immuno-oncology and inflammation.

Before joining the organization, she was responsible for business development in the life sciences department of the regional tech transfer accelerator SATT Conectus Alsace. From 2006 to 2012, Nathalie served as an R&D project leader and team supervisor at Polyplus-transfection. Earlier in her career, she held a clinical project leader position at Forenap pharma following a six-year postdoctoral period at the DKFZ in Heidelberg, Germany, the IRCAD institute and INSERM in Strasbourg, France.

Nathalie holds a PhD in molecular and cellular biology from the University of Strasbourg in France.